MedTrace Logo

Standard Post Market Clinical Follow-up (PMCF) Study WSA @ HZO

NCT06700512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-08-08

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

Hearing Aid Signia Pure C&G 7IX

Receiver in Canal (RIC) hearing aid, M Receiver

DEVICE

Own Hearing Aid

subjects' own hearing aids, any brand, any model

Sponsors & Collaborators

  • WSAUD A/S

    lead INDUSTRY

Principal Investigators

  • Matthias Vormann, PhD · Hörzentrum Oldenburg gGmbH

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-14
Primary Completion
2024-08-13
Completion
2024-08-26

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06700512 on ClinicalTrials.gov